We are live on ! Find out more
Group One Trading

Group One Trading Portfolio holdings

AUM $52.2B
1-Year Est. Return 104.56%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,561.13%
AUM
$7.15B
AUM Growth
+$778M
Cap. Flow
+$799M
Cap. Flow %
11.18%
Top 10 Hldgs %
9.56%
Holding
5,720
New
998
Increased
1,852
Reduced
1,702
Closed
889

Sector Composition

Rank Sector Weight
1 Healthcare 3.37%
2 Technology 1.88%
3 Consumer Discretionary 1.68%
4 Energy 1.47%
5 Financials 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALU
326
DELISTED
Alcatel-Lucent
ALU
$4.86M 0.07%
1,343,083
-723,664
-35% -$2.78M
LUMO
327
PUT
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$4.85M 0.07%
12,178
-10,444
-46% -$4.44M
RRC icon
328
CALL
Range Resources
RRC
$9.43B
$4.85M 0.07%
98,200
+48,000
+96% +$2.74M
SHPG
329
CALL
DELISTED
Shire pic
SHPG
$4.83M 0.07%
20,000
-2,900
-13% -$719K
BHC icon
330
Bausch Health
BHC
$2.62B
$4.79M 0.07%
21,581
+11,138
+107% +$2.47M
CHTR icon
331
Charter Communications
CHTR
$17.2B
$4.79M 0.07%
27,994
+14,202
+103% +$2.55M
ARNA
332
DELISTED
Arena Pharmaceuticals Inc
ARNA
$4.77M 0.07%
102,877
+6,278
+6% +$272K
INFN
333
CALL
DELISTED
Infinera Corporation Common Stock
INFN
$4.77M 0.07%
227,300
-11,600
-5% -$236K
PGEN icon
334
CALL
Precigen
PGEN
$2.36B
$4.74M 0.07%
97,974
-138,288
-59% -$5.83M
HOLX
335
CALL
DELISTED
Hologic
HOLX
$4.74M 0.07%
124,400
+102,200
+460% +$3.58M
VNET
336
VNET Group
VNET
$2.04B
$4.73M 0.07%
230,485
+190,925
+483% +$3.82M
QUNR
337
PUT
DELISTED
Qunar Cayman Islands Limited
QUNR
$4.73M 0.07%
110,300
-19,400
-15% -$909K
CAG icon
338
CALL
Conagra Brands
CAG
$7.14B
$4.72M 0.07%
138,780
-5,526
-4% -$166K
EXAS
339
CALL
DELISTED
Exact Sciences
EXAS
$4.72M 0.07%
158,700
-181,400
-53% -$4.56M
KYTH
340
PUT
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$4.7M 0.07%
62,400
+23,200
+59% +$1.24M
EXC icon
341
CALL
Exelon
EXC
$47B
$4.69M 0.07%
209,178
-29,723
-12% -$712K
ARRY
342
PUT
DELISTED
Array Biopharma Inc
ARRY
$4.64M 0.06%
643,400
+200,000
+45% +$1.48M
LUMN icon
343
CALL
Lumen
LUMN
$6.65B
$4.63M 0.06%
157,600
-176,300
-53% -$6.01M
BUD icon
344
CALL
AB InBev
BUD
$166B
$4.62M 0.06%
38,300
+4,400
+13% +$540K
DB icon
345
PUT
Deutsche Bank
DB
$69.8B
$4.61M 0.06%
171,360
+91,392
+114% +$2.65M
BKS
346
DELISTED
Barnes & Noble
BKS
$4.59M 0.06%
270,003
+40,201
+17% +$627K
VIPS icon
347
CALL
Vipshop
VIPS
$7.47B
$4.56M 0.06%
204,900
+97,400
+91% +$2.58M
BMY icon
348
PUT
Bristol-Myers Squibb
BMY
$134B
$4.53M 0.06%
68,100
+15,000
+28% +$989K
STLA icon
349
Stellantis
STLA
$21.3B
$4.51M 0.06%
476,544
+187,275
+65% +$1.92M
QSR icon
350
PUT
Restaurant Brands International
QSR
$25.3B
$4.49M 0.06%
117,600
-73,800
-39% -$2.91M

Similar funds

Group One Trading's Q2 2015 Portfolio in Review

As of Q2 2015, Group One Trading held 5,720 positions worth $7.15B, up 12% from $6.37B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Group One Trading deployed $799M of net new capital in Q2 2015, opening 998 new positions and adding to 1,852 existing holdings. Its largest new stake was Viatris: 122,934 shares worth $8.34M.

By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, up from 2.9% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Allergan plc, an estimated $21.2M trimmed.

  • Group One Trading's largest Q2 2015 buy was Viatris: 122,934 shares worth $8.34M.
  • Group One Trading added most to Williams Companies in Q2 2015, an estimated $22.3M increase.
  • Group One Trading's biggest Q2 2015 reduction was Allergan plc, cutting an estimated $21.2M.
  • Group One Trading fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $89.2M.
  • Group One Trading's ten largest holdings make up 9.6% of its $7.15B portfolio in Q2 2015.
  • Group One Trading opened 998 new positions and closed 889 in Q2 2015.
  • Group One Trading's portfolio value rose 12% quarter-over-quarter to $7.15B.

Based on Group One Trading's 13F filing for Q2 2015, filed 11 Aug 2015.